Human population studies with cytogenetic biomarkers: Review of the literature and future prospectives
Tóm tắt
Cytogenetic biomarkers are by far the most frequently used endpoints in human population studies. Their sensitivity for measuring exposure to genotoxic agents and their role as early predictors of cancer risk have contributed to this success. In this article, we present an overview of the last 25 years of population studies with cytogenetic biomarkers, describing the evolution of this research and addressing the most promising innovations for the future. The evaluation has been restricted to the most popular assays, i.e., chromosomal aberrations (CAs) and micronucleus (MN), which are considered to be causally related to early stages of chronic diseases, especially cancer, and may therefore play a major role in prevention. An extensive literature search covering the period 1 January 1980 to 31 December 2003 was performed using the Medline/PubMed database. A total of 833 population studies using CAs and 434 using matched MN inclusion criteria were included in the analysis. We report the distribution of selected papers by year of publication, country, language, agents investigated, and methods employed. The state of the art and future prospects regarding cytogenetic techniques and epidemiologic and statistical methods are discussed. The role of susceptibility and its potential impact on genotoxic damage are discussed with special attention to the effect of major genetic polymorphisms on the baseline frequency of CAs and micronuclei. Environ. Mol. Mutagen., 2005. © 2005 Wiley‐Liss, Inc.
Từ khóa
Tài liệu tham khảo
Aka P, 2005, Influence of hOOG1, XRCC1 and XRCC3 genotypes on DNA strand break repair phenotype and biomarkers of genotoxicity in workers exposed to γ‐rays, Radiat Res
Ashby J, 1985, Tabulation and assessment of 113 human surveillance cytogenetic studies conducted between 1965 and 1984, Mutat Res, 154, 113, 10.1016/0165-1110(85)90023-5
Beck JC, 2001, Successful transformation of cryopreserved lymphocytes: a resource for epidemiological studies, Cancer Epidemiol Biomarkers Prev, 10, 551
Bolognesi C, 1997, Age‐related increase of chromosome aberrations, sister‐chromatid exchanges and micronuclei in human lymphocytes, Cancer Epidemiol Biomarkers Prev, 6, 249
Bonassi S, 2000, Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens, Cancer Res, 60, 1619
Clayton D, 1993, Statistical models in epidemiology
Hagmar L, 1994, Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage, Cancer Res, 54, 2919
Hagmar L, 1998, Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH), Cancer Res, 58, 4117
Hayes RB, 2002, Whole blood cryopreservation in epidemiological studies, Cancer Epidemiol Biomarkers Prev, 11, 1496
Hosmer DW, 1989, Applied logistic regression
Knudsen LE, 1999, Chromosomal aberrations in humans induced by urban air pollution: influence of DNA repair and polymorphisms of glutathione S‐transferase M1 and N‐acetyltransferase 2, Cancer Epidemiol Biomarkers Prev, 8, 303
Liou SH, 1999, Increased chromosome‐type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area, Cancer Res, 59, 1481
Piegorsch WW, 1997, Statistics for environmental biology and toxicology
Rothman N, 1995, Incorporating biomarkers into cancer epidemiology: a matrix of biomarker and study design categories, Cancer Epidemiol Biomarkers Prev, 4, 301
Rothman KJ, 1998, Modern epidemiology
Tucker JD, 1997, Cytogenetic end‐points as biological dosimeters and predictors of risk in epidemiological studies
Tucker JD, 2002, Sensitivity, specificity, and persistence of chromosome translocations for radiation biodosimetry, Mil Med, 167, 8, 10.1093/milmed/167.suppl_1.8